|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-5-9
|
|
pubmed:abstractText |
Allergen specific nasal challenge (ASNC) is an optimal model to study the pathophysiologic mechanisms sustaining allergic inflammation, particularly the adhesion molecules promoting cellular infiltration of nasal mucosa. Topical corticosteroids have been accepted as a highly effective anti-inflammatory therapy for allergic rhinitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1081-1206
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11345288-Administration, Intranasal,
pubmed-meshheading:11345288-Adolescent,
pubmed-meshheading:11345288-Adult,
pubmed-meshheading:11345288-Allergens,
pubmed-meshheading:11345288-Anti-Allergic Agents,
pubmed-meshheading:11345288-Anti-Inflammatory Agents,
pubmed-meshheading:11345288-Blood Proteins,
pubmed-meshheading:11345288-Double-Blind Method,
pubmed-meshheading:11345288-Eosinophil Granule Proteins,
pubmed-meshheading:11345288-Eosinophilia,
pubmed-meshheading:11345288-Eosinophils,
pubmed-meshheading:11345288-Female,
pubmed-meshheading:11345288-Humans,
pubmed-meshheading:11345288-Intercellular Adhesion Molecule-1,
pubmed-meshheading:11345288-Leukocyte Count,
pubmed-meshheading:11345288-Male,
pubmed-meshheading:11345288-Middle Aged,
pubmed-meshheading:11345288-Nasal Lavage Fluid,
pubmed-meshheading:11345288-Nasal Mucosa,
pubmed-meshheading:11345288-Nasal Provocation Tests,
pubmed-meshheading:11345288-Neutrophils,
pubmed-meshheading:11345288-Pregnadienediols,
pubmed-meshheading:11345288-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:11345288-Ribonucleases,
pubmed-meshheading:11345288-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
|
|
pubmed:affiliation |
Allergy & Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy. giocip@unige.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
